disease

Latest Posts

Curetopia, a Biotech DAO, leverages decentralized science to speed up uncommon illness research Zug, Switzerland,...

Blockchain

Biotech Neighborhood Curetopia Raises $1.77M to Advance Uncommon Illness Cures with Blockchain – Blockchain Information Web site

PADOVA examine confirmed numerical delay in motor development and constructive developments on a number...

Market

Roche’s Part IIb Examine of Prasinezumab Missed Major Endpoint, However Suggests Doable Medical Profit in Early-Stage Parkinson’s Illness By Investing.com

By Abdollah Ag Mohamed TINZAOUATEN, Mali (Reuters) - Residents of Mali's northern city...

Market

Mali city at coronary heart of July battle hit by illness and drone strikes By Reuters

(Reuters) -The U.S. Meals and Drug Administration has accepted Elanco Animal Well...

Market

US FDA approves Elanco’s pores and skin illness therapy for canines By Reuters

First and solely BTK inhibitor to display favorable general survival pattern vs. standard-of-care chemoimmunotherapy...

Market

CALQUENCE ® (acalabrutinib) plus chemoimmunotherapy decreased the chance of illness development or dying by 27% vs. customary of care in sufferers with untreated mantle...

Tinlarebant is Belite Bio's orally administered pill meant to sluggish illness development in sufferers...

Market

Belite Bio Receives Sakigake (Pioneer Drug) Designation of Tinlarebant for Stargardt Illness in Japan By Investing.com

‹‹‹First and solely EGFR inhibitor and focused remedy to point out profit in Stage...

Market

TAGRISSO ® (osimertinib) decreased the danger of illness development or demise by 84% in sufferers with unresectable, Stage III EGFR-mutated lung most cancers vs....